TYLER, Texas, Nov. 17, 2006 (PRIMEZONE) -- The Board of Directors of Biogenerics Limited (Pink Sheets:BIGN) is pleased to issue this current update on the progress of the Company's business.
Name Change of Company -- The Company anticipates changing its operational name in order to identify the Company more readily with the oil/gas industry. The Board projects this name change to occur during the first quarter of 2007. The potential new names for the Company are being considered at this time and a final name will be chosen in the near future. At that time, the Company will release a press release regarding this name change.
Authorized and Outstanding Common Shares of the Company -- As of the above date, the Company has approx. 376,500,000 outstanding shares of common stock and has authorized shares of common stock approved by the State of Nevada in the amount of 800,000,000. This increase in authorized shares was made in order to have shares available for the Company's future business needs which may include, but not be limited to, Joint Ventures, Asset Purchases, Management Compensation and any other necessary business transactions the Company's Board of Directors feels is necessary to carry on the Company's business.
East Texas Oil Field -- The Company has obtained in principal, a funding commitment to conclude this transaction, which is subject to and contingent upon the funder performing a satisfactory site and field inspection of the East Texas Oil Field. This will include interviewing personnel at the operations, obtaining commitments from Key Personnel to continue with the new operations in their current positions, auditing the existence of all active wells including past production reports in order to substantiate the monthly production of the field, inventory of all equipment and inventories for operations of the field and any other item they may feel necessary to complete this transaction with the Company and its joint venture partners. The Company has obtained assistance from Royal Petroleum Corporation in this transaction in order to obtain the financial strength to conclude this potential business transaction. At this time, the Company is endeavoring to push this transaction to close before this current calendar year end.
If successful, the Company will receive, as its part of the Joint Venture transaction an operational facility located in Central, Louisiana, that involves 30 working and active wells that will produce over 3500 bbls/oil/month which will be free and clear of all debt. This field has a Geologist Report showing its current value being in excess of $13 million. This project will produce an annual net income in excess of $1,800,000. In addition, the Company will receive a cash position of $4 million for further investment in the oil and gas industry via "Farm-outs" and direct working interest investments.
In summary, if concluded this joint venture transaction will place over $17 million of economic asset value into BIGN with no debt and a joint venture association with the operating company of the East Texas Oil Field for future business associations.
While the primary focus is completing the East Texas Oil Field Joint Venture transaction, the Board of Directors is also giving careful consideration to the following issues:
-- Restructuring the business agreements with Joint Venture partner Hydroslotter Corp., the NC-02 technology and considering alternative well renewal technologies to better serve the companies future requirements both technically and economically.
-- Expansion of current operations in New Mexico and Oklahoma as the company may determine to be viable.
-- Continued re-organizing of the virtual I.R Department providing more accessibility to company business activity while maintaining an open line of communication to shareholders.
-- The Company has received a notification from the Pink Sheets organization regarding new requirements and the Company will endeavor to meet the highest standards for future reporting and compliance.
These decisions will be tailored around the expected conclusion of the East Texas Oil Field Joint Venture transaction.
Summary -- The Company is entering into a new era in its business growth and development. In doing so, many changes are needed in order for the Company to take advantage of and to exploit the many business opportunities it has available to it.
The Company would like to thank its shareholders for their patience and understanding during this period of change and growth, which brings with it uncertainties and daily decisions to make for the benefit of all concerned. Your Company is worth your respect and is only as good as its shareholders say it is no matter how successful management is in performing its duties.
Website: http://www.bignltd.com
About Biogenerics Limited
Biogenerics is a diversified investment venture capital firm focused on exploiting and distributing domestic oil and gas reserves. Biogenerics also has joint venture activities with Tyche Energy Inc and Hydroslotter Corp.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.